Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 668

Researchers at Duke-NUS Medical School have identified interleukin-11 (IL11) as a key factor in the ageing process. Elevated IL11 levels lead to fat accumulation and muscle loss—two major indicators of ageing. Inhibiting IL11 could enhance healthy lifespans.

Ageing populations pose significant health and economic challenges globally. Even a one-year increase in life expectancy could be valued at $38 trillion.

In a study published in Nature, the team demonstrated that anti-IL11 therapy not only counters the harmful effects of ageing but also increases lifespan by up to 25% in preclinical models. The therapy shifts metabolism from generating harmful white fat to beneficial brown fat, which helps burn calories and maintain body temperature.

Read more | >

Organizations are losing between $94 — $186 billion annually to vulnerable or insecure APIs (Application Programming Interfaces) and automated abuse by bots. That’s according to The Economic Impact of API and Bot Attacks report from Imperva, a Thales company. The report highlights that these security threats account for up to 11.8% of global cyber events and losses, emphasizing the escalating risks they pose to businesses worldwide.

Drawing on a comprehensive study conducted by the Marsh McLennan Cyber Risk Intelligence Center, the report analyzes over 161,000 unique cybersecurity incidents. The findings demonstrate a concerning trend: the threats posed by vulnerable or insecure APIs and automated abuse by bots are increasingly interconnected and prevalent. Imperva warns that failing to address security risks associated with these threats could lead to substantial financial and reputational damage.

Read more | >

A widely available and inexpensive antidepressant drug may soon save lives from an altogether different kind of disease.

The growth of the most aggressive and deadly brain cancer, glioblastoma, was effectively suppressed in both ex vivo human tissue samples and in living mice by an FDA approved serotonin modulator currently used to treat major depression.

It’s not a cure, but it may offer some relief and constitute an effective part of a treatment regime for glioblastoma patients. Human clinical trials are the next step; patients are cautioned against self-medicating at this stage.

Read more | >

Plant-based diets have grown in popularity owing to multiple health and environmental benefits.

Here, the authors describe the evidence concerning plant-based dietary patterns and omnivorous diets with reduced consumption of animal-based food and increased consumption of plant-based foods and their associations with the most common urological cancers and benign urological conditions.

Read more | >

Researchers have developed an algorithm that could dramatically reduce the energy consumption of artificial intelligence systems.

Ad.

Scientists at BitEnergy AI created a method called “Linear-complexity multiplication” (L-Mul) that replaces complex floating-point multiplications in AI models with simpler integer additions.

Read more | >